Loading...
Daxor Corporation
DXR•NASDAQ
Healthcare
Medical - Instruments & Supplies
$8.75
$-0.04(-0.46%)
Daxor Corporation (DXR) Financial Performance & Statements
Review Daxor Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
1203.92%
↑ 1203.92%
Operating Income Growth
-601.88%
↓ 601.88%
Net Income Growth
91.11%
↑ 91.11%
Operating Cash Flow Growth
100.70%
↑ 100.70%
Operating Margin
248.71%
↑ 248.71%
Gross Margin
90.27%
↑ 90.27%
Net Profit Margin
69.92%
↑ 69.92%
ROE
1.57%
↑ 1.57%
ROIC
5.21%
↑ 5.21%
Daxor Corporation (DXR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Daxor Corporation stock.
| Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $71756.00 | $36.35M | $41224.00 | -$1.76M |
| Cost of Revenue | $0.00 | -$4636.00 | $0.00 | $439316.00 |
| Gross Profit | $71756.00 | $36.36M | $41224.00 | -$2.20M |
| Gross Profit Ratio | $1.00 | $1.000 | $1.00 | $1.25 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $369306.00 | $251508.00 | $251508.00 | $218024.00 |
| Operating Expenses | $369306.00 | $1.62M | $1.62M | $1.54M |
| Total Costs & Expenses | $369306.00 | $33.29M | $1.62M | $1.23M |
| Interest Income | $0.00 | $0.00 | $2318.00 | $22233.00 |
| Interest Expense | $0.00 | $4636.00 | $0.00 | $44466.00 |
| Depreciation & Amortization | $300836.00 | $210793.00 | $210793.00 | $183229.00 |
| EBITDA | -$3.17M | $3.06M | $0.00 | -$2.99M |
| EBITDA Ratio | -$44.15 | $0.08 | $45.35 | $1.70 |
| Operating Income | -$297550.00 | $3.06M | -$210793.00 | -$2.99M |
| Operating Income Ratio | -$4.15 | $0.08 | -$5.11 | $1.70 |
| Other Income/Expenses (Net) | -$2.96M | $252969.00 | $1.87M | -$44466.00 |
| Income Before Tax | -$3.26M | $3.32M | $1.66M | -$3.04M |
| Income Before Tax Ratio | -$45.45 | $0.09 | $40.24 | $1.73 |
| Income Tax Expense | -$1.63M | $1.00 | $1.87M | -$1.00 |
| Net Income | -$1.63M | $3.32M | $1.66M | -$3.04M |
| Net Income Ratio | -$22.73 | $0.09 | $40.24 | $1.73 |
| EPS | -$0.34 | $0.69 | $0.35 | -$0.68 |
| Diluted EPS | -$0.34 | $0.69 | $0.35 | -$0.68 |
| Weighted Avg Shares Outstanding | $4.83M | $4.81M | $4.81M | $4.46M |
| Weighted Avg Shares Outstanding (Diluted) | $4.83M | $4.81M | $4.81M | $4.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan